Rigel Pharmaceuticals (RIGL) Change in Receivables (2014 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Change in Receivables of -$1.8 million for Q1 2026, down 2573.53% year-over-year from $73498.2 in Q1 2025, and down 131.14% quarter-over-quarter from $5.8 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Change in Receivables (2014 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Change in Receivables history runs 12 years deep, the most recent figure standing at -$1.8 million for Q1 2026.
- In Q1 2026, Change in Receivables fell 2573.53% year-over-year to -$1.8 million; the TTM figure through Mar 2026 stood at $8.4 million (down 40.16% YoY), while the FY2025 annual figure was $10.1 million, down 8.29% from the prior year.
- Change in Receivables for Q1 2026 stood at -$1.8 million, down from $5.8 million in the prior quarter.
- The five-year high for Change in Receivables was $24.8 million in Q4 2022, with the low at -$11.0 million in Q1 2023.
- The 5-year median for Change in Receivables is $1.4 million (2024), against an average of $2.0 million.
- The sharpest annual moves came in 2022 and 2023: Change in Receivables jumped 5054.89% in 2022, then slumped 4621.55% in 2023.
- Rigel Pharmaceuticals' Change in Receivables stood at $24.8 million in 2022, then tumbled by 71.75% to $7.0 million in 2023, then surged by 57.62% to $11.0 million in 2024, then sank by 47.12% to $5.8 million in 2025, then tumbled by 131.14% to -$1.8 million in 2026.
- Business Quant data shows RIGL's Change in Receivables at -$1.8 million in Q1 2026, $5.8 million in Q4 2025, and $6.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.10 Mn |
| Jun 30, 2026 | 6.10 Mn |
| Mar 31, 2026 | -1.82 Mn |
| Mar 31, 2026 | -1.82 Mn |
| Dec 31, 2025 | 5.84 Mn |
| Dec 31, 2025 | 5.84 Mn |
| Sep 30, 2025 | 6.02 Mn |
| Sep 30, 2025 | 6.02 Mn |
| Jun 30, 2025 | -1.64 Mn |
| Jun 30, 2025 | -1.64 Mn |
| Mar 31, 2025 | -68,000.00 |
| Mar 31, 2025 | -68,000.00 |
| Dec 31, 2024 | 11.04 Mn |
| Dec 31, 2024 | 11.04 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.39 Mn |
| Jun 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | -3.04 Mn |
| Mar 31, 2024 | -3.04 Mn |